Your Article Summary
US Department of Health and Human Services (HHS) purchases GSKs A (H1N1) influenza antigen and proprietary adjuvant system
GlaxoSmithKline, 05/27/09
GSK announced that the US Department of Health and Human Services has placed initial orders for A influenza vaccine antigen and the company's proprietary adjuvant system, AS03, to support its pandemic influenza preparation efforts. GSK manufactures both a traditional vaccine antigen, which will be made from the recently isolated A influenza strain, as well as an adjuvant system. An adjuvant system can be added to the antigen at time of administration.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Bristol-Myers Squibb and Mead Johnson Announce Amendment and Extension of Exchange Offer
Bristol Myers-Squibb Company, 12/07/09
Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09
Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09
Article Search
Sponsor


See Latest Articles


